Transdermal drug-delivery firm TDS Pharm confident of growth ahead of IPC
TDS Pharm CEO Kim Chul-jun makes a presentation at a press conference on Thursday. (KBR photo). TDS Pharm, which specializes in transdermal drug delivery systems, revealed its future growth strategy and vision following its upcoming listing on the Kosdaq …